Frailty, failure to thrive, disability Flashcards
1
Q
Fraility
A
- AGS 2004: “a state of increased vulnerability to stressors due to age-related declines in physiologic reserve across neuromuscular, metabolic, and immune systems”
- 7-10% in population
- asian, african-american, female,
- SARCOPENIA, or age-related skeletal muscle WASTING and muscle strength, is a key physiologic component.
- Hormonal changes including lower levels of IGF-1 and DHEA-S, and higher levels of cortisol
- weight loss, slow walking speed, and low physical activity, and cognitive impairment were independently associated with disability, long-term nursing home residence, poor-surgical outcome and death.
2
Q
Cardiovascular Health Study index
A
3 out of 5
- Weight loss (≥5 percent of body weight in last year)
- Exhaustion (positive response to questions regarding effort required for activity)
- Motor Weakness (decreased grip strength)
- Slow walking speed (gait speed) (>6 to 7 seconds to walk 15 feet)
- Decreased physical activity (Kcals spent per week: males expending <383 Kcals and females <270 Kcal)
3
Q
Disability
A
- A state of difficulty or dependency in completing tasks essential for self-care and independent living.
- 20-30% in elderly
*
4
Q
ADLs
A
- Ambulate
- Bathing
- Controling bowel/ bladder
- Dressing
- Feeding
- Transfers
5
Q
Failure to Thrive
A
- A syndrome of global decline that occurs in elders as an aggregate of physical FRAILITY, COGNITIVE IMPAIRMEN, and functional DISABILITY; which resulted in declining functional status
- multiple contributing factors, including medication side effects, medical comorbidities, and psychosocial factors.
6
Q
Management FTT
A
- Treat underlying REVERSIBLE courses
- DISCONTINUE unnecessary medications.
- REMOVED: Dietary restrictions and patient’s preference diet.
- Nutritional supplements between meals.
- Assistance with feeding.
- AVOID routinely appetite stimulants (marginal benefit).
- Exercise
- Vit-D suppement
- Agreesively treat depression: antidepressants, a trial of a low-dose psychostimulant (methylphenidate 2.5 mg), or shock therapy.
7
Q
Hospice eleigibility
A
Non-disease specific criteria
- KPS<50
- 3/6 dependent in ADLs
- Idiopathic Weight loss >10%/6mo
- Albumin<2.5
- Recurrent or intractable infections
- Recurrent aspiration and/or inadequate oral intake due to intractable dysphagia
- Progressing dementia by objective measures
- Progressive pressure ulcers (stage 3 or 4) despite optimal care